Outcomes in Schizophrenia Systematic Reviews
|
|
- Annabella Woods
- 5 years ago
- Views:
Transcription
1 Outcomes in Schizophrenia Systematic Reviews Jouko Miettunen Professor of Clinical Epidemiology Center for Life Course Epidemiology and Systems Medicine, University of Oulu, Finland This project is co-funded by the EC under H2020 research and innovation
2 AIMS The aim is to present recent systematic reviews related to long-term outcome of schizophrenia. Included reviews focus different aspects of schizophrenia Proportion of recovery Duration of untreated psychosis (DUP) as a predictor of outcome Family history of psychosis as a predictor of functional outcome 2
3 General methods of included systematic reviews several electronic databases Scopus, PubMed, Science Direct, ISI Web of Knowledge, PsycINFO (Ovid), CINAHL (EBSCO) and Academic Search Premier (EBSCO) and manual literature search Included articles were required to meet following criteria: at least 80% of the participants were individuals with a schizophreniaspectrum diagnosis follow-up time was at least 2 years since onset of illness majority of the subjects were older than 16 years at the onset of psychotic symptoms Clinical trials were excluded 3
4 Recovery criteria: improvements in both clinical and social domains and evidence that improvement in at least one of these two domains had persisted for at least two years 4
5 Recovery in schizophrenia In 50 studies, the median proportion of recovery was 13.5% Mean 16.4%, range 0-58% Studies from sites in countries with poorer economic status had higher recovery proportions. 5
6 Recovery in subpopulations 6
7 Gender differences in recovery 7
8 Recovery - Conclusion Based on the best available data, approximately one in seven individuals with schizophrenia met our criteria for recovery. Large heterogeneity in results and in methods. Despite major changes in treatment options in recent decades, the proportion of recovered cases has not increased. This project is co-funded by the EC under H2020 research and innovation 8
9 Duration of untreated psychosis and outcome 9
10 Duration of untreated psychosis and outcome 10
11 DUP - Conclusion Longer duration of untreated psychosis associated with poorer outcomes Average effect sizes were quite small Results indicate that early intervention may have subtle positive effects on outcome of schizophrenia This project is co-funded by the EC under H2020 research and innovation 11
12 Family history of psychosis and outcome 12
13 Family history of psychosis and global outcome 13
14 Family history - Conclusion Based on the review the presence of family history of psychosis has a relatively small but statistically significant negative effect on the occupational and global (i.e. combined occupational, social and clinical) outcome. This was the first systematic review on effects of family history on social aspects of outcome in schizophrenia. A previous review (Esterberg et al. Schizophr Res 2010; 120:121-30) has found a small but significant negative effect of family history on negative symptoms but not on positive symptoms (no follow-up required). These results have clinical relevance, such as possibility to direct interventions to the patient group with increased risk of poorer outcome. 14
15 Other potential outcome predictors Substance use Approximately 25% of schizophrenia patients have a cannabis use disorder and 20% have a alcohol use disorder Koskinen et al. Acta Psychiatr Scand 2009; 120:85-96 Koskinen et al. Schizophr Bull 2010; 36: Those who continue to abuse substances have worse outcome Gupta et al. Aust N Z J Psychiatry. 2013; 47: Large et al. Aust N Z J Psychiatry 2014; 48: Medications and medication adherence Leucht et al. Lancet 2012; 379: Emsley et al. BMC Psychiatry 2013; 13:50 Zipursky et al. J Clin Psychiatrry 2014; 75 (Suppl. 2):20-24 Onset age? Marital status? Adverse life events? 15
16 Main references Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, Veijola J, Miettunen J. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull 2013; 39: Käkelä J, Panula J, Oinas E, Hirvonen N, Jääskeläinen E, Miettunen J. Family history of psychosis and social, occupational and global outcome in schizophrenia: a meta-analysis. Acta Psychiatr Scand 2014; 130: Penttilä M, Jääskeläinen E, Hirvonen N, Isohanni M, Miettunen J. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia. A systematic review and metaanalysis. Br J Psychiatry 2014; 205:
17 Jouko Miettunen, prof.; Erika Jääskeläinen, adjunct prof. Center for Life Course Epidemiology and Systems Medicine, University of Oulu, Oulu, Finland & Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland Matti Penttilä, MScD; Pauliina Juola, MScD; Juha Käkelä, BMed; Matti Isohanni, prof. Center for Clinical Neurosciences, University of Oulu, Oulu, Finland & Department of Psychiatry, Oulu University Hospital, Oulu, Finland Noora Hirvonen, MA Information Studies, Faculty of Humanities, University of Oulu, Oulu, Finland John J McGrath, prof; Sukanta Saha, PhD University of Queensland, St Lucia, Australia This project is co-funded by the EC under H2020 research and innovation jouko.miettunen@oulu.fi / 17
Long-term associations between use of antipsychotic medication and brain structural changes in schizophrenia
Long-term associations between use of antipsychotic medication and brain structural changes in schizophrenia a systematic review and a meta-analysis Jouko Miettunen Center for Life Course Epidemiology
More informationSystematic reviews and meta-analyses
Systematic reviews and meta-analyses Oulu 8.4.2015 Jouko Miettunen, professor Center for Life Course Epidemiology and Systems Medicine University of Oulu jouko.miettunen@oulu.fi Contents Background Literature
More informationDuration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis {
The British Journal of Psychiatry (2014) 205, 88 94. doi: 10.1192/bjp.bp.113.127753 Review article Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review
More informationOccupational Therapy for First Episode Psychosis
2018 International OT Conference Occupational Therapy for First Episode Psychosis Ms. Yeung Sau Fong, Odelia Occupational Therapy Department Kwai Chung Hospital HKSAR Early intervention Stage specific
More informationSelf-labelling and stigma as predictors of attitudes towards help-seeking among people at risk of psychosis: 1 year follow-up
Self-labelling and stigma as predictors of attitudes towards help-seeking among people at risk of psychosis: 1 year follow-up Ziyan Xu, Mario Müller, Karsten Heekeren, Anastasia Theodoridou, Diane Dvorsky,
More informationPOT WEED CHRONIC GREEN KUSH BUD HERB
POT WEED CHRONIC GREEN KUSH BUD HERB WHAT MOTIVATES YOU TO USE POT?* AVOID USING CANNABIS RELAXES ME HELPS ME FIT IN HELPS ME FORGET MAKES ME FEEL HAPPY HELPS ME SLEEP CHANGES MY REALITY *Though there
More informationPrognosis of schizophrenia spectrum disorder may not be predetermined during early
Prognosis of schizophrenia spectrum disorder may not be predetermined during early development the Northern Finland Birth Cohort 1966 Nina Rautio, a,b Juha Käkelä, a,c,d Tanja Nordström, a,d Jouko Miettunen,
More informationResults. NeuRA Family relationships May 2017
Introduction Familial expressed emotion involving hostility, emotional over-involvement, and critical comments has been associated with increased psychotic relapse in people with schizophrenia, so these
More informationInformation about the Critically Appraised Topic (CAT) Series
Information about the Critically Appraised Topic (CAT) Series The objective of the Doctor of Nursing Practice (DNP) program at George Mason University is to prepare graduates for the highest level of nursing
More information6th International Conference on Early Psychosis
OR015. Story production in first episode psychosis: the role of verbal learning memory and verbal fluency HJ Stain,1 S Hodne,2 I Joa,2 JO Johannesen,2 BR Rund,3 W ten Velden Hegelstad,2 TK Larsen2 1Centre
More informationXXIV Paulo International Medical Symposium Schizophrenia - Epidemiology and Biology
XXIV Paulo International Medical Symposium Schizophrenia - Epidemiology and Biology June 18 th to 20 th, 2012 Oulu, Finland Program and abstracts Organisers: Oulu Psychiatric Epidemiology Society (OPES)
More informationACTA SYSTEMATIC SEARCH AND EVALUATION OF PUBLISHED SCIENTIFIC RESEARCH IMPLICATIONS FOR SCHIZOPHRENIA RESEARCH UNIVERSITATIS OULUENSIS D 1067
OULU 2010 D 1067 ACTA Johanna Mäkinen UNIVERSITATIS OULUENSIS D MEDICA SYSTEMATIC SEARCH AND EVALUATION OF PUBLISHED SCIENTIFIC RESEARCH IMPLICATIONS FOR SCHIZOPHRENIA RESEARCH FACULTY OF MEDICINE, INSTITUTE
More informationResults. NeuRA Worldwide incidence April 2016
Introduction The incidence of schizophrenia refers to how many new cases there are per population in a specified time period. It is different from prevalence, which refers to how many existing cases there
More informationHandout for the Neuroscience Education Institute (NEI) online activity: First-Episode Schizophrenia: Setting the Stage for Successful Outcomes
Handout for the Neuroscience Education Institute (NEI) online activity: First-Episode Schizophrenia: Setting the Stage for Successful Outcomes Learning Objectives Initiate low-dose antipsychotic medication
More informationNeuRA Schizophrenia diagnosis May 2017
Introduction Diagnostic scales are widely used within clinical practice and research settings to ensure consistency of illness ratings. These scales have been extensively validated and provide a set of
More informationSukanta Saha, 1 James Scott, 1,2,3,4 Daniel Varghese, 5 John McGrath 1,4,6
Open Access To cite: Saha S, Scott J, Varghese D, et al. Anxiety and depressive disorders are associated with delusional-like experiences: a replication study based on a National Survey of Mental Health
More informationSchizophrenia: Early Intervention
Focus on CME at The University of Western Ontario Schizophrenia: Early Intervention Rahul Manchanda, MD, MRCPsych, FRCP(C); and Ross M.G. Norman, PhD, CPsych Presented at A Psychiatric Update 2003, Regional
More informationImpact of antipsychotics on long-term course of psychotic illness. Donald Goff, MD Nathan Kline Institute NYU School of Medicine
Impact of antipsychotics on long-term course of psychotic illness Donald Goff, MD Nathan Kline Institute NYU School of Medicine Disclosures Dr. Goff receives research support from NIMH, the Stanley Foundation
More informationSeparable developmental trajectories in schizophrenia from womb to grave: results from the Northern Finland 1966 Birth Cohort.
1. Tieteellinen esitys: Separable developmental trajectories in schizophrenia from womb to grave: results from the Northern Finland 1966 Birth Cohort. 2. Voidaanko hoitoyhteisömallilla vaikuttaa skitsofrenian
More informationBGS Falls Severe mental illness, poor bone health and falls: The potential role for physical activity
Severe mental illness, poor bone health and falls: The potential role for physical activity Brendon Stubbs MCSP, PhD Head of Physiotherapy South London and Maudsley NHS Foundation Trust Post Doctoral Research
More informationMethod. NeuRA Negative symptoms April 2016
Introduction The negative symptoms of schizophrenia refer to an absence of normal functions. This may include (but is not limited to); blunted affect, which is a scarcity of facial expressions of emotion,
More informationThe impact of antipsychotic side effects on attitudes toward medication in patients with schizophrenia: A systematic review
JBI Systematic Review Protocol The impact of antipsychotic side effects on attitudes toward medication in patients with schizophrenia: A systematic review Chiang Yan Ling 1, Piyanee Klainin 2, Jeanette
More informationEarly Psychosis Services: Philadelphia PEACE Program
Early Psychosis Services: Philadelphia PEACE Program Irene Hurford, M.D. Clinical Director, PEACE Program, Horizon House Assistant Professor, Department of Psychiatry, University of Pennsylvania 1 John
More informationEarly identification of neurobiological markers of remission. Michael Bodnar, PhD Ashok K. Malla, MD Martin Lepage, PhD
Early identification of neurobiological markers of remission Michael Bodnar, PhD Ashok K. Malla, MD Martin Lepage, PhD Outline Why study remission? Defining remission Data collection Results neurocognition
More informationResearch Article Predicting Depression with Psychopathology and Temperament Traits: The Northern Finland 1966 Birth Cohort
Depression Research and Treatment Volume 2012, Article ID 160905, 9 pages doi:10.1155/2012/160905 Research Article Predicting Depression with Psychopathology and Temperament Traits: The Northern Finland
More informationSuicides In Schizophrenia And Paranoid Psychoses (Acta Psychiatrica Scandinavica) By Matti Virkkunen
Suicides In Schizophrenia And Paranoid Psychoses (Acta Psychiatrica Scandinavica) By Matti Virkkunen If searching for the ebook by Matti Virkkunen Suicides in schizophrenia and paranoid psychoses (Acta
More informationBeyond clozapine: a review of the literature on clozapine resistance
Beyond clozapine: a review of the literature on clozapine resistance Jan Bogers j.bogers@ggzleiden.nl www.clozapinepluswerkgroep.nl Dutch Clozapine Collaboration Group Mental Health Services Rivierduinen
More informationResults. NeuRA Motor dysfunction April 2016
Introduction Subtle deviations in various developmental trajectories during childhood and adolescence may foreshadow the later development of schizophrenia. Studies exploring these deviations (antecedents)
More informationNovember 2014 MRC2.CORP.X.00004
This program is paid for by Otsuka America Pharmaceutical, Inc. and Lundbeck, LLC. The speaker is a paid consultant of Otsuka America Pharmaceutical, Inc. advice or professional diagnosis. Users seeking
More informationNeuRA Schizophrenia diagnosis June 2017
Introduction Diagnostic scales are widely used within clinical practice and research settings to ensure consistency of illness ratings. These scales have been extensively validated and provide a set of
More informationNeuRA Decision making April 2016
Introduction requires an individual to use their knowledge and experience of a context in order to choose a course of action 1. A person s ability to autonomously make decisions is referred to as their
More informationLifetime use of psychiatric medications and cognition at 43 years of age in schizophrenia in the Northern Finland
Lifetime use of psychiatric medications and cognition at 43 years of age in schizophrenia in the Northern Finland Birth Cohort 1966 Anja P. Hulkko 1,2,3*, Graham K. Murray 4,5, Jani Moilanen 1,2,3, Marianne
More informationAssociation between Global Assessment of Functioning scores and indicators of functioning, severity, and prognosis in first-time schizophrenia
Clinical Epidemiology open access to scientific and medical research Open Access Full Text Article ORIGINAL RESEARCH Association between Global Assessment of Functioning scores and indicators of functioning,
More informationRole of social media and the Internet in pathways to care for adolescents and young adults with psychotic disorders and non-psychotic mood disorders
Journal Articles Donald and Barbara Zucker School of Medicine Academic Works 2015 Role of social media and the Internet in pathways to care for adolescents and young adults with psychotic disorders and
More informationUrbanization and the Determinants of Health: The Cities Changing Diabetes Programme
Urbanization and the Determinants of Health: The Cities Changing Diabetes Programme Rome December 11, 2017 A. David Napier Professor Medical Anthropology, University College London Director Science, Medicine,
More informationSchizoaffective Disorder
Roseanna Parkhurst-Gatewood MSN FNP-BC, PMHNP-BC DSM-5 diagnostic criteria for schizoaffective disorder 3 A. An uninterrupted period of illness during which there is a major mood episode (major depressive
More informationMETHODS RESULTS. Supported by funding from Ortho-McNeil Janssen Scientific Affairs, LLC
PREDICTORS OF MEDICATION ADHERENCE AMONG PATIENTS WITH SCHIZOPHRENIC DISORDERS TREATED WITH TYPICAL AND ATYPICAL ANTIPSYCHOTICS IN A LARGE STATE MEDICAID PROGRAM S.P. Lee 1 ; K. Lang 2 ; J. Jackel 2 ;
More informationKing s Research Portal
King s Research Portal DOI: 10.1016/j.encep.2016.04.004 Document Version Peer reviewed version Link to publication record in King's Research Portal Citation for published version (APA): Yang, H., & Young,
More informationBrief Report Duration of untreated psychosis and acute remission of negative symptoms in a South American first-episode psychosis cohort
bs_bs_banner First Impact Factor released in June 2010 and now listed in MEDLINE! Early Intervention in Psychiatry 2015; : doi:10.1111/eip.12266 Brief Report Duration of untreated psychosis and acute remission
More informationThe British Approach to Understanding and Treating Psychosis
The British Approach to Understanding and Treating Psychosis Robin M Murray Professor of Psychiatric Research Department of Psychosis Studies Institute of Psychiatry robin.murray@kcl.ac.uk Which boy will
More informationSchizophrenia: New Concepts for Therapeutic Discovery
Schizophrenia: New Concepts for Therapeutic Discovery William T. Carpenter, M.D. Professor of Psychiatry and Pharmacology University of Maryland School of Medicine Department of Psychiatry Maryland Psychiatric
More informationThe outlook for schizophrenia is better than we think but is being sabotaged by Assembly-line Psychiatry
The outlook for schizophrenia is better than we think but is being sabotaged by Assembly-line Psychiatry Robin M Murray Department of Psychosis Studies Institute of Psychiatry King s College London robin.murray@kcl.ac.uk
More informationWhat if... there was nothing to recover?
Mental Health: Policies, Practices and Partner March 29, 2 What if... there was nothing to recover? Shelley Levin, Ph.D., L.C.S.W. Regional Director of Staff Development Telecare Corporation slevin@telecarecorp.com
More informationResults. NeuRA Forensic settings April 2016
Introduction Prevalence quantifies the proportion of individuals in a population who have a disease during a specific time period. Many studies have reported a high prevalence of various health problems,
More informationIndividualising antipsychotic treatment for patients with schizophrenia John Donoghue Liverpool
Copyright John Donoghue 2015 Individualising antipsychotic treatment for patients with schizophrenia John Donoghue Liverpool Copyright John Donoghue 2015 QUESTIONS Why do outcomes in schizophrenia remain
More informationTreatment of Schizophrenia
Treatment of Schizophrenia Conduct comprehensive assessment and use measurement-based care as found in the Principles of Practice (review pages 4-7). Most importantly assess social support system (housing,
More informationLinking the Developmental and Degenerative Theories of Schizophrenia: Association Between Infant Development and Adult Cognitive Decline
Schizophrenia Bulletin vol. 40 no. 6 pp. 1319 1327, 2014 doi:10.1093/schbul/sbu010 Advance Access publication March 1, 2014 Linking the Developmental and Degenerative Theories of Schizophrenia: Association
More informationResults. NeuRA Treatments for dual diagnosis August 2016
Introduction Many treatments have been targeted to improving symptom severity for people suffering schizophrenia in combination with substance use problems. Studies of dual diagnosis often investigate
More informationAssociation between family history of psychiatric disorders and long-term outcome in
5 th October 2016 Abstract 186 words Manuscript 3657 words Tables = 3 Figures = 1 Association between family history of psychiatric disorders and long-term outcome in schizophrenia the Northern Finland
More informationEffectiveness of early intervention in psychosis Eóin Killackey a,b and Alison R. Yung a,c
Effectiveness of early intervention in psychosis Eóin Killackey a,b and Alison R. Yung a,c Purpose of review Over 15 years, early intervention in psychosis has grown to become a mainstream funded approach
More informationACTA FAMILY HISTORY OF MENTAL DISORDERS AND LONG-TERM OUTCOME IN SCHIZOPHRENIA UNIVERSITATIS OULUENSIS D Juha Käkelä MEDICA OULU 2018
OULU 2018 D 1462 ACTA Juha Käkelä UNIVERSITATIS OULUENSIS D MEDICA FAMILY HISTORY OF MENTAL DISORDERS AND LONG-TERM OUTCOME IN SCHIZOPHRENIA UNIVERSITY OF OULU GRADUATE SCHOOL; UNIVERSITY OF OULU, FACULTY
More informationEffect of Instructional Module on Drug Adherence in Terms of Attitude among Patients with Schizophrenia
Original Article NUJHS Vol. 6, No.1, March 2016, ISSN 2249-7110 Effect of Instructional Module on Drug Adherence in Terms of Attitude among Patients with Schizophrenia 1 S. Mary Metilda, S. Santhi² & G.
More informationObiettivo del trattamento della schizofrenia: RECOVERY FUNZIONALE
Obiettivo del trattamento della schizofrenia: RECOVERY FUNZIONALE Autonomia abitativa Relazioni interpersonali Attività del tempo libero Lavoro/scuola Symptom remission alone is inadequate for a definition
More informationNeuRA Obsessive-compulsive disorders October 2017
Introduction (OCDs) involve persistent and intrusive thoughts (obsessions) and repetitive actions (compulsions). The DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) defines
More informationW. De La Haye, M.D., M.P.H., D.M. Department of Community Health & Psychiatry, The University of the West Indies, Mona Campus, JAMAICA
W. De La Haye, M.D., M.P.H., D.M. Department of Community Health & Psychiatry, The University of the West Indies, Mona Campus, JAMAICA Less severe mental disorder/more severe substance abuse disorder
More informationC U R R I C U L U M V I T A E
C U R R I C U L U M V I T A E 1. Full name Miettunen, Jouko Antero male 2. Date and place of birth, nationality, current residence, other Date and place of birth: Simo, Finland, September 23, 1967 Nationality:
More informationUniversity of Dundee DOI: / Publication date: Document Version Peer reviewed version
University of Dundee Outcomes following firstepisode psychosis Lappin, Julia M.; Heslin, Margaret; Jones, Peter B.; Doody, Gillian A.; Reininghaus, Ulrich A.; Demjaha, Arsime; Croudace, Timothy; JamiesonCraig,
More informationNeuRA Schizophrenia diagnosis October 2017
Introduction Diagnostic scales are widely used within clinical practice and research settings to ensure consistency of illness ratings. These scales have been extensively validated and provide a set of
More informationThe Long-term Prognosis of Delirium
The Long-term Prognosis of Jane McCusker, MD, DrPH, Professor, Epidemiology and Biostatistics, McGill University; Head, Clinical Epidemiology and Community Studies, St. Mary s Hospital, Montreal, QC. Nine
More informationCannabis for Medical Use: Body and Mind
Cannabis for Medical Use: Body and Mind Shaul Schreiber, MD Division of Psychiatry, Tel Aviv Sourasky Medical Center; Tel Aviv University Sackler Faculty of Medicine; Sagol School of Neuroscience, Israel
More informationImproving outcomes of first-episode psychosis: an overview
FORUM IMPROVING OUTCOMES OF FIRST-EPISODE PSYCHOSIS Improving outcomes of first-episode psychosis: an overview Paolo Fusar-Poli 1,2, Patrick D. McGorry 3,JohnM.Kane 4 1 Early Psychosis: Interventions and
More informationPredictors of schizophrenia a review
Predictors of schizophrenia a review Pirjo Mäki # *, Juha Veijola*, Peter B. Jones, Graham K. Murray, Hannu Koponen*, Pekka Tienari*, Jouko Miettunen*, Päivikki Tanskanen*, Karl-Erik Wahlberg*, Johanna
More informationApplied Psychology Subject Guide
Applied Psychology Subject Guide Need some background information in Psychology-related topics? Start here! Background Information Sources: Print: Houdé, O. (Ed.). (2004). Dictionary of cognitive science:
More informationVALIDATION IN PROCESS
The Scale for Early Psychosis Relapse Risk Assessment (SEPRRA) Clinician PATIENT NAME (Last, First) Assessment Date (DD/MM/YYYY) Assessment Completed By: DEMOGRAPHICS AND CLINICAL INFORMATION Gender Male
More informationDoes Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery?
Schizophrenia Bulletin doi:10.1093/schbul/sbt034 Schizophrenia Bulletin Advance Access published March 19, 2013 At Issue Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate
More informationOffice Practice Coding Assistance - Overview
Office Practice Coding Assistance - Overview Three office coding assistance resources are provided in the STABLE Resource Toolkit. Depression & Bipolar Coding Reference: n Provides ICD9CM and DSM-IV-TR
More informationAbstract: "Evidence-Based Psychotherapy for Schizophrenia: Past, Present, and Future (Intermediate)
Shaun M. Eack, PhD David E. Epperson Professor of Social Work and Professor of Psychiatry School of Social Work and Department of Psychiatry University of Pittsburgh Pittsburgh, PA Abstract: "Evidence-Based
More informationHocus Pocus: How the National Institute of Mental Health Made Two Million People with Schizophrenia Disappear
PREVALENCE January 2018 Hocus Pocus: How the National Institute of Mental Health Made Two Million People with Schizophrenia Disappear By E. Fuller Torrey and Elizabeth Sinclair Although he has been the
More informationA Systematic Review of the Efficacy and Clinical Effectiveness of Group Analysis and Analytic/Dynamic Group Psychotherapy
A Systematic Review of the Efficacy and Clinical Effectiveness of Group Analysis and Analytic/Dynamic Group Psychotherapy Executive summary Aims of the review The main aim of the review was to assess the
More informationReligious Beliefs and Their Relevance for Adherence to Treatment in Mental Illness: A Review
Religious Beliefs and Their Relevance for Adherence to Treatment in Mental Illness: A Review Pawel Zagozdzon, Magdalena Wrotkowska Department of Hygiene and Epidemiology Medical University of Gdansk 1
More informationIs Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A
Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A Faculty/Presenter Disclosures Faculty: Mike Allan Salary: College
More informationPsychosocial intervention to optimal treatment to patients with schizophrenia: neurocognitive perspectives
Psychosocial intervention to optimal treatment to patients with schizophrenia: neurocognitive perspectives TANG Tze-Chun Department of psychiatry KMUH Pharmacotherapy alone or combination with psychotherapy?
More informationOUR TEAM OUR SPECIALIZED PROGRAMS
OUR TEAM Gracie Square Hospital offers a multidisciplinary approach to care for patients with psychiatric disorders who can benefit from inpatient hospitalization. Our treatment programs are provided by
More informationIs Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A
Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A Faculty/Presenter Disclosures Faculty: Mike Allan Salary: College
More informationTreatment Outcomes from the TDC: A Look at Smoking Cessation Among Patients with Co- Occurring Disorders
University of Kentucky From the SelectedWorks of Chizimuzo T.C. Okoli December, 2010 Treatment Outcomes from the TDC: A Look at Smoking Cessation Among Patients with Co- Occurring Disorders Chizimuzo T.C.
More informationAccurate Diagnosis of Primary Psychotic Disorders
Accurate Diagnosis of Primary Psychotic Disorders The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental Health Netsmart
More informationEARLY ONSET SCHIZOPHRENIA
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences EARLY ONSET SCHIZOPHRENIA JON MCCLELLAN CHILD STUDY AND TREATMENT CENTER GENERAL DISCLOSURES The University of Washington
More informationEarly Intervention Teams services for early psychosis
Early Intervention Teams services for early psychosis Early intervention services work with people who are usually between 14 and 35, and are either at risk of or are currently experiencing a first episode
More informationSupplementary Online Content
Supplementary Online Content Vorstman JAS, Breetvelt EJ, Duijff SN, et al; International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Cognitive decline preceding the onset of psychosis
More informationThe Paranoid Patient: Perils and Pitfalls
The Paranoid Patient: Perils and Pitfalls Phillip J. Resnick, MD Professor of Psychiatry Case Western Reserve University Director of Forensic Psychiatry University Hospitals Case Medical Center Cleveland,
More informationEarly psychosis intervention
Review Article Singapore Med J 2010, 51(9) 689 Early psychosis intervention Yap H L ABSTRACT Early psychosis intervention programmes have been around for 20 years. The duration of psychosis has been hypothesised
More informationThe Global Research Framework of Cities Changing Diabetes. Prof. David Napier Global Academic Lead Cities Changing Diabetes
The Global Research Framework of Cities Changing Diabetes Prof. David Napier Global Academic Lead Cities Changing Diabetes Today, two thirds of people with diabetes live in cities 2017 65% OF PEOPLE WITH
More informationResponding to the Challenge of Treatment of Individuals with Co-occurring Substance Abuse and Psychotic Disorders: A Focus on Youth and Young Adults
Responding to the Challenge of Treatment of Individuals with Co-occurring ubstance Abuse and Psychotic Disorders: A Focus on Youth and Young Adults Lisa Dixon, M.D., M.P.H. New York tate Psychiatric Institute
More informationLUP. Lund University Publications Institutional Repository of Lund University
LUP Lund University Publications Institutional Repository of Lund University This is an author produced version of a paper published in Schizophrenia Research. This paper has been peerreviewed but does
More informationReview Article The promise of early intervention
Early Intervention in Psychiatry 2007; 1: 294 307 doi:10.1111/j.1751-7893.2007.00043.x Review Article The promise of early intervention Jean Addington 1,2,3 1 Department of Psychiatry, University of Toronto,
More informationNeuRA Sleep disturbance April 2016
Introduction People with schizophrenia may show disturbances in the amount, or the quality of sleep they generally receive. Typically sleep follows a characteristic pattern of four stages, where stage
More informationDEFINITION OF TERMS BACKGROUND. APNA 27th Annual Conference Session 2023: October 10, Boardman 1
A problem solving based peer support program for enhancing adherence to oral antipsychotic medication in consumers with schizophrenia Dr. Gayelene Boardman Lecturer, Discipline Leader Mental Health Nursing
More informationSupplementary Online Content
Supplementary Online Content Subotnik KL, Casaus LR, Ventura J, et al. Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia:
More informationA Systematic Review of the Effect of Early Interventions for Psychosis on the Usage of Inpatient Services
Schizophrenia Bulletin vol. 41 no. 6 pp. 1379 1386, 2015 doi:10.1093/schbul/sbv016 Advance Access publication March 5, 2015 A Systematic Review of the Effect of Early Interventions for Psychosis on the
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Schoeler T, Petros N, Di Forti M, et al. Poor
More informationSELECTED EPIDEMIOLOGICAL ASPECTS OF SCHIZOPHRENIA: A CROSS SECTIONAL STUDY AT TERTIARY CARE HOSPITAL IN MAHARASHTRA
Original Article SELECTED EPIDEMIOLOGICAL ASPECTS OF SCHIZOPHRENIA: A CROSS SECTIONAL STUDY AT TERTIARY CARE HOSPITAL IN MAHARASHTRA Madhura D Ashturkar 1, Jaggnath V Dixit 2 Financial Support: None declared
More informationEarly intervention in psychosis: another triumph of hope over experience?
Early intervention in psychosis: another triumph of hope over experience? Ann Mortimer MD, FRCPsych, Timothy Brown BSc (hons) Evidence that longer duration of untreated psychosis (DUP) was associated with
More informationGender Difference and PANSS Score of Paranoid Schizophrenia Using Risperidone
Gender Difference and PANSS Score of Paranoid Schizophrenia Using Risperidone Abstract Andreas Xaverius Bangun * M Surya Husada Bahagia Loebis Faculty of Medicine, University of Sumatera Utara, Jalan dr.
More informationDoes Family Structure Play a Role in Depression in Adolescents Admitted to Psychiatric Inpatient Care?
Child Psychiatry Hum Dev (2016) 47:918 924 DOI 10.1007/s10578-015-0622-3 ORIGINAL ARTICLE Does Family Structure Play a Role in Depression in Adolescents Admitted to Psychiatric Inpatient Care? Matti Laukkanen
More informationMental Health Current Articles Bulletin - April 2018
Library and Knowledge Services Mental Health Current Articles Bulletin - April 2018 How to Obtain an Article If you would like to request any articles included in this bulletin, or to be put onto the bulletin
More informationManagement of physical health conditions in adults with severe mental disorders
Management of physical health conditions in adults with severe mental disorders WHO GUIDELINES EVIDENCE PROFILES Tobacco cessation Weight management Substance use disorders Cardiovascular disease and cardiovascular
More informationTrajectories of Symptom Dimensions in Short- Term Response to Antipsychotic Treatment in Patients with a First Episode of Non-Affective Psychosis
University of Kentucky UKnowledge Psychiatry Faculty Publications Psychiatry -0 Trajectories of Symptom Dimensions in Short- Term Response to Antipsychotic Treatment in Patients with a First Episode of
More informationReceived 11 August 2015; Accepted 23 February 2016; First published online 28 March Introduction
Epidemiology and Psychiatric Sciences (2017), 26, 314 324. Cambridge University Press 2016 doi:10.1017/s2045796016000123 ORIGINAL ARTICLE A comparison of the cumulative incidence and early risk factors
More informationFidelity and Outcomes in Community Care
Faculty Disclosure Alex Kopelowicz, MD Dr. Kopelowicz has listed no financial interest/arrangement that would be considered a conflict of interest. Fidelity and Outcomes in Community Care Alex Kopelowicz,
More information